Skip to content

Author

Yoshinobu Fuse

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Predicting Chemoresistance in HER2-low Breast Cancer: Histologic Grade, MRI Non-mass Enhancement, and Clinical T Stage

Background/Aim: Human epidermal growth factor receptor 2 (HER2)-low breast cancer shows consistently low pathological complete response (pCR) rates after neoadjuvant chemotherapy (NAC), yet no preoperative tool exists to identify non-responders for whom alternative strategies – including upfront surgery or early trastu...

Yoshinobu Fuse, Atsushi Fushimi, Ayano Nameki et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.